Quan Shen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Generation of an autophagy-targeting influenza A virus as live attenuated vaccine.
Journal: Nature communications
Published: September 17, 2025
Author Correction: PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins.
Journal: Nature chemical biology
Published: June 12, 2025
Lysosome-targeting live attenuated influenza vaccines elicit robust and broad immunity in mice.
Journal: Nature communications
Published: May 30, 2025
Attenuation of Influenza a Virus into Live Vaccines Through C-End Degrons.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 23, 2025
Synthetic biology-inspired development of live attenuated influenza vaccines.
Journal: NPJ vaccines
Published: April 09, 2025
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2.
Journal: Microorganisms
Published: March 13, 2025
PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins.
Journal: Nature chemical biology
Published: July 16, 2023
Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection.
Journal: Nature microbiology
Published: March 28, 2023
Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking.
Journal: Medicine
Published: August 12, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Journal: Nature communications
Published: July 27, 2022
Establishment of human distal lung organoids for SARS-CoV-2 infection.
Journal: Cell discovery
Published: May 31, 2021
Last Updated: 09/26/2026